- Home
- VOR vs PRME Comparison
VOR vs PRME Comparison
Compare VOR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | PRME |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 767.4M | 666.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VOR | PRME |
|---|---|---|
| Price | $13.73 | $3.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $45.33 | $7.56 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | N/A | $47.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $0.13 | $1.11 |
| 52 Week High | $49.95 | $6.94 |
Technical Indicators
Market Signals| Indicator | VOR | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 50.22 |
| Support Level | $11.38 | $3.17 |
| Resistance Level | $16.87 | $3.94 |
| Average True Range (ATR) | 1.23 | 0.22 |
| MACD | -0.25 | 0.04 |
| Stochastic Oscillator | 3.32 | 60.12 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.